Glucose
dehydrogenase (GDH) generally functions as an expensive
cofactor NAD(P)H regenerator in an enzyme-coupled cofactor regeneration
system, as in the production of fine chemicals. However, whether GDH
can accept substrates other than glucose remains to be explored. Based
on a known mutant of GDH with high thermostability, DN46 (E170K–K252L),
we employed semirational design-based directed evolution to expand
its substrate scope and promote its application in the asymmetric
synthesis of methyl 2-hydroxyl carboxylates. After one round of saturation
mutagenesis and two rounds of iterative saturation mutagenesis, an
enantioselectivity-enhanced mutant DN46-E96Q-H147V (>99% ee, R-preference) and enantioselectivity-reversed mutant DN46-E96Q-I150A-W152L
with high enantioselectivity (>97% ee, S-preference)
evolved. With glucose as a cosubstrate, we developed a dual-function
GDH-based substrate-coupled cofactor regeneration system for asymmetric
synthesis. Furthermore, in light of a deeper understanding of the
catalytic mechanism, a rational design was successfully performed
to create a mutant DN46-W152G for the upscaled synthesis of (R)-2-chloromandelic acid methyl ester, the precursor of
the medicine (S)-clopidogrel. This work expands the
utilization of GDH, provides a design method for rational design of
this enzyme, and will support future work regarding its application
toward achieving even broader substrate scope.